Advances in Surgical and Management of Cardiac and Vascular Diseases
The attendee should gain an understanding of cardiovascular risk reduction, cardiac rehabilitation and the management of adults with congenital heart disease. The attendee should become familiar with newer pharmacologic treatment of congestive heart failure and acute coronary syndrome. He or she should learn latest treatment for aortic and mitral valve disease and peripheral vascular disease. The attendee will develop a better understanding of the implications of current efforts in health care reform.
8:00-8:05 Opening Remarks
8:05-8:45 Phil Ades, MD University of Vermont College of Medicine Risk Factor identification and Reduction - Key elements of a effective Cardiac Rehabilitation program
8:45-9:25 Martin Le Winter, MD - University of Vermont College of Medicine Pharmaceutical Treatment of congestive heart failure—optimizing medication and dosages - why we don’t hit the target
9:25 -9 40 Break, visit exhibits and sponsors
9:40 - 10:20 Jonathan Halperin, MD Shepherding anti-platelet and anti-thrombotic thearapy in 2011
10:20-11:00 Andrew Eisenhauer MD - Bringham Women's Medical Center Percutaneous Aortic Valve Replacement
11:00 - 11:30 Panel Discussion
11:30 -12:30 Lunch, visit exhibits and sponsors
12:30 -12:35 Introductions
12:35-1:15 The Michael M. Frymus, M.D. Memorial Lecture Steven F. Bolling MD University of Michigan Mitral Valve Repair in the Patient with Left Ventricle Dysfunction.
1:15:- 1:55 Michael Gewitz MD, Maria Fareri Children Hospital at Westchester Medical Center Managing the emerging labyrinth of adults with corrected congenital heart disease.
1:55 - 2:35 Richard Hsu, MD, Danbury Hospital Offering optimal therapy to patients with carotid arterial disease, stenting vs endarterectomy
2:35 - 3:15 Shawn Friesen - Government Affairs Associate You can not change the wind but you can adjust the sails, the future of health care.
3:15 - 3:40 Panel discussion and closing remarks
Continuing Medical Education
Danbury Hospital has designated this educational activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Attendees should only claim credit commensurate with the extent of their participation in the activity.
Primary Care Physicians, Cardiologists, Cardiovascular and Vascular Surgeons, Nurses and Mid-Level Providers with an interest in Cardiovascular Disease
Robilotti Conference Center
24 Hospital Ave
Register Now >>